Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANGION BIOMEDICA CORP.

(ANGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ANGION BIOMEDICA CORP.
01/05ANGION BIOMEDICA : Current Corporate Presentation
PU
01/05ANGION BIOMEDICA : Results of Operations and Financial Condition - Form 8-K
PU
01/04Angion Provides Corporate Update and Announces Participation in Upcoming Investor Confe..
AQ
01/04Angion Biomedica Corp. Provides ANG-3070 Program Update
CI
2021Health Care Stocks Holding Onto Midday Gains
MT
2021Angion Biomedica Jumps in Pre-Market Trading After CEO Jay Venkatesan Acquires More Tha..
MT
2021Oppenheimer Adjusts Angion Biomedica PT to $8 From $15, Maintains Outperform Rating
MT
2021Angion Biomedica, Vifor Pharma's Mid-Stage Trial of Acute Kidney Injury Drug Fails to M..
MT
2021Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in..
BU
2021Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in ..
GL
2021Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in ..
GL
2021INSIDER SELL : Angion Biomedica
MT
2021Angion Provides Corporate Update and Reports Third Quarter 2021 Financial Results - For..
PU
2021Angion Biomedica Corp. Reports Earnings Results for the Third Quarter and Nine Months E..
CI
2021Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q3 Loss $-0.53
MT
More most relevant news
All news about ANGION BIOMEDICA CORP.
01/05ANGION BIOMEDICA : Current Corporate Presentation
PU
01/05ANGION BIOMEDICA : Results of Operations and Financial Condition - Form 8-K
PU
01/04ANGION BIOMEDICA CORP. : Results of Operations and Financial Condition, Costs Associated w..
AQ
01/04Angion Provides Corporate Update and Announces Participation in Upcoming Investor Confe..
AQ
01/04Angion Biomedica Corp. Provides ANG-3070 Program Update
CI
2021Health Care Stocks Holding Onto Midday Gains
MT
2021Health Care Stocks Flat To Higher Premarket Thursday
MT
2021Angion Biomedica Jumps in Pre-Market Trading After CEO Jay Venkatesan Acquires More Tha..
MT
2021Oppenheimer Adjusts Angion Biomedica PT to $8 From $15, Maintains Outperform Rating
MT
2021Health Care Stocks Mixed Premarket Friday
MT
More news
News in other languages on ANGION BIOMEDICA CORP.
01/04Angion Biomedica Corp. fait le point sur le programme ANG-3070
2021Les actions du secteur de la santé en hausse ou en baisse jeudi avant le marché
2021Les actions du secteur de la santé sont mitigées vendredi avant le marché
2021L'essai de mi-parcours d'Angion Biomedica et de Vifor Pharma sur un médicament contre l..
2021Earnings Flash (ANGN) ANGION BIOMEDICA annonce un chiffre d'affaires de 1,5 million de ..
2021Wall Street fait du sur-place avant la cloche et consolide après que le Dow et le S&P a..
2021L'essai de phase tardive d'Angion Biomedica sur un médicament pour la transplantation r..
2021Angion Biomedica déclare que l'essai de phase avancée d'un médicament pour la transplan..
2021Earnings Flash (ANGN) ANGION BIOMEDICA annonce un chiffre d'affaires de 540 000 $ pour ..
2021Angion Biomedica annonce des résultats positifs dans une étude de stade précoce sur un ..
More news
Analyst Recommendations on ANGION BIOMEDICA CORP.
2021Oppenheimer Adjusts Angion Biomedica PT to $8 From $15, Maintains Outperform Rating
MT
2021HC Wainwright Adjusts Angion Biomedica's Price Target to $50 From $100, Reiterates Buy ..
MT
2021Stifel Adjusts Price Target on Angion Biomedica to $15 from $40, Keeps Buy Rating
MT
2021Oppenheimer Adjusts Angion Biomedica PT to $15 From $38, Maintains Outperform Rating
MT
2021ANGION BIOMEDICA : Oppenheimer Initiates Coverage on Angion Biomedica With Outperform Rati..
MT
More recommendations
Press releases
01/05ANGION BIOMEDICA : Current Corporate Presentation
PU
01/05ANGION BIOMEDICA : Results of Operations and Financial Condition - Form 8-K
PU
01/04ANGION BIOMEDICA CORP. : Results of Operations and Financial Condition, Costs Associated w..
AQ
01/04Angion Provides Corporate Update and Announces Participation in Upcoming Investor Confe..
AQ
2021Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in..
BU
More press releases
Upcoming event on ANGION BIOMEDICA CORP.
03/29/22